// App-Quantinova.ai

1287 : Radiomics and delta-radiomics signatures to predict response and survival in patient with non-small cell lung cancer treated with immune checkpoint inhibitors

Researchers

Presenter

  • Francois Cousin

Principal Investigators

  • Thomas Louis

  • Mariaelena Occhipinti

  • Wim Vos

  • Julien Guiot

  • Roland Hustinx

Medical Centers

  • 5University Hospital Centre of Liège Liège Belgium

  • Radiomics, Liege, Belgium

Locations

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved